{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T05:13:21Z","timestamp":1786511601805,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.expneurol.2004.08.014","type":"journal-article","created":{"date-parts":[[2004,10,5]],"date-time":"2004-10-05T15:08:50Z","timestamp":1096988930000},"page":"506-514","source":"Crossref","is-referenced-by-count":55,"title":["Role of dietary iron restriction in a mouse model of Parkinson's disease"],"prefix":"10.1016","volume":"190","author":[{"given":"Cathy W.","family":"Levenson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy G.","family":"Cutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Ladenheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean L.","family":"Cadet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Hare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Mattson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2004.08.014_bb0005","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000419350","article-title":"Structural and functional studies of human ferritin H and L chains","volume":"58","author":"Arosio","year":"1991","journal-title":"Curr. Stud. Hematol. Blood Transfus."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0010","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/ageing\/27.5.631","article-title":"A prospective study of dementia with Lewy bodies","volume":"27","author":"Ballard","year":"1998","journal-title":"Age Ageing"},{"issue":"5 Suppl. 1","key":"10.1016\/j.expneurol.2004.08.014_bb0015","doi-asserted-by":"crossref","first-page":"1468S","DOI":"10.1093\/jn\/133.5.1468S","article-title":"Iron deficiency alters brain development and functioning","volume":"133","author":"Beard","year":"2003","journal-title":"J. Nutr."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0020","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0166-4328(02)00092-X","article-title":"Neurobehavioral analysis of developmental iron deficiency in rats","volume":"34","author":"Beard","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0025","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/jn\/133.4.1174","article-title":"Neonatal iron deficiency results in irreversible changes in dopamine function in rats","volume":"133","author":"Beard","year":"2003","journal-title":"J. Nutr."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0030","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0301-5629(99)00046-0","article-title":"Iron accumulation in the substantia nigra in rats visualized by ultrasound","volume":"25","author":"Berg","year":"1999","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0035","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ana.10312","article-title":"Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis","volume":"52","author":"Cutler","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0040","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1161\/01.CIR.0000066910.02844.D0","article-title":"Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis","volume":"107","author":"Day","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.expneurol.2004.08.014_bb0045","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/ajcn\/77.1.56","article-title":"Iron status in association with cardiovascular disease risk in 3 controlled feeding studies","volume":"77","author":"Derstine","year":"2003","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0050","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0140-6736(87)91361-4","article-title":"Increased nigral iron content in postmortem parkinsonian brain","volume":"2","author":"Dexter","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2004.08.014_bb0060","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ana.10350","article-title":"p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism","volume":"52","author":"Duan","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0065","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1093\/jn\/130.11.2831","article-title":"Iron deficiency alters dopamine transporter functioning in rat striatum","volume":"130","author":"Erickson","year":"2000","journal-title":"J. Nutr."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0070","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0091-3057(01)00563-9","article-title":"Iron deficiency decreases D1 and D2 receptors in rat brain","volume":"69","author":"Erickson","year":"2001","journal-title":"Pharm. Biochem. Behav."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0075","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/ajcn\/76.6.1375","article-title":"Dietary factors associated with the risk of high iron stores in the elderly Framingham Heart Study cohort","volume":"76","author":"Fleming","year":"2002","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0006-8993(94)91586-5","article-title":"Nordihydroguaiaretic acid protects hippocampal neurons against amyloid beta-peptide toxicity, and attenuates free radical and calcium accumulation","volume":"654","author":"Goodman","year":"1994","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0085","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1212\/WNL.45.6.1138","article-title":"Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease","volume":"45","author":"Gorell","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2004.08.014_bb0090","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1073\/pnas.73.7.2424","article-title":"Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor","volume":"73","author":"Green","year":"1976","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0095","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/1531-8257(199907)14:4<612::AID-MDS1010>3.0.CO;2-6","article-title":"Apomorphine protects against MPTP-induced neurotoxicity in mice","volume":"4","author":"Grunblatt","year":"1999","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0100","doi-asserted-by":"crossref","first-page":"SII95","DOI":"10.1007\/PL00022909","article-title":"MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson's disease: neuroprotective strategies","volume":"247","author":"Grunblatt","year":"2000","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0105","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1471-4159.2001.t01-1-00227.x","article-title":"Effects of R- and S-apomorphine on MPTP-induced nigro-striatal dopamine neuronal loss","volume":"77","author":"Grunblatt","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0110","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1471-4159.2000.0750314.x","article-title":"Beneficial effects of dietary restriction on cerebral cortical synaptic terminals: preservation of glucose and glutamate transport and mitochondrial function after exposure to amyloid beta-peptide, iron, and 3-nitropropionic acid","volume":"75","author":"Guo","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0115","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0891-5849(03)00385-X","article-title":"Dopaminergic cell death precedes iron elevation in MPTP-injected monkeys","volume":"35","author":"He","year":"2003","journal-title":"Free Radical Biol. Med."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0120","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1301\/nr.2003.febr.45-62","article-title":"Health implications of iron overload: the role of diet and genotype","volume":"61","author":"Heath","year":"2003","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0125","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0021-9150(98)00070-7","article-title":"Lack of association between ferritin level and measures of LDL oxidation: the ARIC study. Atherosclerosis Risk in Communities","volume":"139","author":"Iribarren","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.expneurol.2004.08.014_bb0130","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0896-6273(03)00126-0","article-title":"Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease","volume":"37","author":"Kaur","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2004.08.014_bb0135","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.arr.2004.03.001","article-title":"Iron and ageing: an introduction to iron regulatory mechanisms","volume":"3","author":"Levenson","year":"2004","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0140","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1212\/WNL.49.3.714","article-title":"Altered systemic iron metabolism in Parkinson's disease","volume":"49","author":"Logroscino","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2004.08.014_bb0145","first-page":"S13","article-title":"Dietary iron, animal fats, and risk of Parkinson's disease","volume":"13","author":"Logroscino","year":"1998","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0150","first-page":"23","article-title":"Behavioral aspects of iron deficiency","volume":"14","author":"Lozoff","year":"1986","journal-title":"Prog. Hematol."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0155","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1542\/peds.112.4.846","article-title":"Behavioral and developmental effects of preventing iron-deficiency anemia in healthy full-term infants","volume":"112","author":"Lozoff","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.expneurol.2004.08.014_bb0160","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0091-679X(08)61930-5","article-title":"Calcium, free radicals, and excitotoxic neuronal death in primary cell culture","volume":"46","author":"Mattson","year":"1995","journal-title":"Methods Cell Biol."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0165","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0006-3223(03)00530-4","article-title":"Prevalence, etiology, and treatment of depression in Parkinson's disease","volume":"54","author":"McDonald","year":"1996","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.expneurol.2004.08.014_bb0170","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0304-3940(94)90462-6","article-title":"Iron accumulation in the substantia nigra of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian monkeys","volume":"168","author":"Mochizuki","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0175","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1753-4887.2001.tb07002.x","article-title":"Iron and colorectal cancer risk: human studies","volume":"59","author":"Nelson","year":"2001","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0180","first-page":"S35","article-title":"Mechanisms of MPTP toxicity","volume":"13","author":"Przedborski","year":"1998","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0185","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0065-230X(01)82002-9","article-title":"p53-dependent apoptosis pathways","volume":"82","author":"Shen","year":"2001","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0190","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF01244786","article-title":"Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain","volume":"74","author":"Sofic","year":"1988","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0195","doi-asserted-by":"crossref","first-page":"44284","DOI":"10.1074\/jbc.M105343200","article-title":"Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure","volume":"276","author":"Uversky","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0200","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1385\/NMM:1:3:171","article-title":"Zinc inhibits the nuclear translocation of the tumor suppressor protein p53 and protects cultured human neurons from copper-induced neurotoxicity","volume":"1","author":"VanLandingham","year":"2002","journal-title":"Neuromolecular Med."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0205","series-title":"Brain Iron: Neurochemical and Behavioural Aspects","first-page":"25","article-title":"Iron dependent enzymes in the brain","author":"Wigglesworth","year":"1988"},{"key":"10.1016\/j.expneurol.2004.08.014_bb0210","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1749-6632.1999.tb07977.x","article-title":"The pivotal role of iron in NF-kappa B activation and nigrostriatal dopaminergic neurodegeneration. Prospects for neuroprotection in Parkinson's disease with iron chelators","volume":"890","author":"Youdim","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0215","first-page":"83","article-title":"Iron chelating, antioxidant and cytoprotective properties of dopamine receptor agonist; apomorphine","volume":"58","author":"Youdim","year":"2000","journal-title":"J. Neural Transm., Suppl."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0220","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1385\/JMN:15:2:85","article-title":"Pivotal role for acidic sphingomyelinase in cerebral ischemia-induced ceramide and cytokine production, and neuronal apoptosis","volume":"15","author":"Yu","year":"2000","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.expneurol.2004.08.014_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01243515","article-title":"Rapid and simple method for measuring biogenic amines and metabolites in brain homogenates by HPLC-electrochemical detection","volume":"53","author":"Zaczek","year":"1982","journal-title":"J. Neural Transm."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488604003401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488604003401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T12:53:45Z","timestamp":1682772825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488604003401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0014488604003401"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2004.08.014","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}